the first Ebola virus nucleic acid diagnostic kit in China
In August 2014, PRK developed the first Ebola virus nucleic acid diagnostic kit in China.
established joint research center with the top research institution in China
PRK partnered with Academy of Military Medicine which is the top research institution in China and established joint research center. Since foundation, PRK undertook more than 15 national and local high-tech R&D programs and national 863 program.
In 2020, the joint developed product 2019-nCov RT-PCR-Fluorescence Probing passed the ministry expert assessment and exclusively obtained the registration Certificate of Special Provisions for drugs in the People’s Liberation Amy. (Military Drug Standard Q2020001)
Academy of Military Medicine, who is the R&D partner of PRK, tied for first place with Chinese Academy of Inspection and Quarantine on the number of patents in the filed of detection and diagnosis of COVID-19.